secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nu-Med Plus, Inc. (NUMD)
CIK:        0001543637
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001548123-24-000067
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 3.03, 3.02, 1.01, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nu-Med Plus completes acquisition of YourSpace America, new CEO and majority control shift
--------------------------------------------------------------------------------

- Nu-Med Plus acquires YourSpace America via share exchange; YSA becomes wholly owned subsidiary as of April 28, 2024.
- Consideration: 4.5M shares of Series A Preferred (convertible to 90M common shares, 20:1 voting) and 1M Series X Preferred (100:1 voting).
- Series X Preferred issued to William R. Colvin, granting him majority voting control of the combined company.
- William R. Colvin appointed President, CEO, and Director; former CEO William Hayde becomes Executive Chairman.
- An audit of YSA for the prior two fiscal years is pending; amended 8-K to be filed upon completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1543637/000154812324000067/0001548123-24-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1543637/000154812324000067/numd8-k42824.htm
  HTML page:      https://secwatch.observer/filing/0001548123-24-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer